PMV Pharmaceuticals, Inc. Common Stock (NASDAQ: PMVP) last traded at $1.52, up 2.01% on the session. The quote above updates while this page is open; the figures below are drawn from PMV Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
PMV Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker PMVP. Its market capitalisation is $81.26 million.
Valuation measures for PMV Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $81.26M |
|---|---|
| Enterprise value | $79.36M |
| Price / book | 1.14 |
| Beta | 0.55 |
Trailing-twelve-month figures tagged in PMV Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$75.22M |
| EPS (TTM) | -$1.41 |
|---|
| Return on equity | -105.20% |
|---|
| Cash | $12.47M |
|---|
Range and volume for PMVP over the past 52 weeks.
| 52-week high | $1.91 |
|---|---|
| 52-week low | $1.02 |
| Volume | 891.7K |
| Average volume | 664.9K |
| Previous close | $1.49 |
Invest a chosen dollar amount in PMV Pharmaceuticals, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell PMVP.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.